Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for MGNX

Stock NameMacroGenics Inc
TickerMGNX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS5560991094
LEI5493001KJQUA83L8MH79

Show aggregate MGNX holdings

News associated with MGNX

MacroGenics (NASDAQ:MGNX) Now Covered by Analysts at Barclays
Research analysts at Barclays initiated coverage on shares of MacroGenics (NASDAQ:MGNX – Get Free Report) in a report issued on Wednesday, Marketbeat.com reports. The firm set an “overweight” rating and a $3.00 price target on the biopharmaceutical company’s stock. Barclays‘s price target would suggest a potential upside of 73.41% from the stock’s previous close. Several […] - 2025-09-19 02:50:55
MacroGenics (NASDAQ:MGNX) Upgraded by Barclays to Strong-Buy Rating
Barclays upgraded shares of MacroGenics (NASDAQ:MGNX – Free Report) to a strong-buy rating in a report issued on Tuesday morning,Zacks.com reports. Several other research firms also recently weighed in on MGNX. B. Riley dropped their target price on shares of MacroGenics from $5.00 to $3.00 and set a “neutral” rating for the company in a […] - 2025-09-19 02:02:52
MacroGenics, Inc. (NASDAQ:MGNX) Receives $3.60 Consensus Target Price from Analysts
Shares of MacroGenics, Inc. (NASDAQ:MGNX – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are covering the stock, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating, two have given a buy rating and one has assigned a strong buy […] - 2025-09-15 02:12:59
MacroGenics (NASDAQ:MGNX) Stock Price Crosses Below 200 Day Moving Average – Should You Sell?
Shares of MacroGenics, Inc. (NASDAQ:MGNX – Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $1.68 and traded as low as $1.64. MacroGenics shares last traded at $1.64, with a volume of 911,663 shares changing hands. Wall Street Analyst Weigh In MGNX […] - 2025-08-26 05:18:57
MacroGenics, Inc. (NASDAQ:MGNX) Receives Average Rating of “Moderate Buy” from Analysts
Shares of MacroGenics, Inc. (NASDAQ:MGNX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven ratings firms that are covering the firm, Marketbeat reports. Four research analysts have rated the stock with a hold rating, two have given a buy rating and one has given a strong buy rating to […] - 2025-08-18 05:23:02
MacroGenics, Inc. (NASDAQ:MGNX) Receives Average Recommendation of “Hold” from Analysts
MacroGenics, Inc. (NASDAQ:MGNX – Get Free Report) has been assigned a consensus recommendation of “Hold” from the ten analysts that are currently covering the company, Marketbeat Ratings reports. Seven analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and one has assigned a strong buy recommendation to the company. […] - 2025-07-24 05:11:01
MacroGenics (NASDAQ:MGNX) Raised to Hold at Wall Street Zen
MacroGenics (NASDAQ:MGNX – Get Free Report) was upgraded by research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Saturday. Several other analysts have also weighed in on MGNX. Barclays reaffirmed an “overweight” rating and issued a $3.00 price objective (down […] - 2025-07-14 03:40:47
MacroGenics, Inc. (NASDAQ:MGNX) Receives $5.71 Average PT from Analysts
Shares of MacroGenics, Inc. (NASDAQ:MGNX – Get Free Report) have received an average recommendation of “Hold” from the ten brokerages that are currently covering the stock, MarketBeat reports. Seven equities research analysts have rated the stock with a hold recommendation, two have given a buy recommendation and one has given a strong buy recommendation to […] - 2025-07-02 02:22:52
MacroGenics, Inc. (NASDAQ:MGNX) Given Consensus Rating of “Hold” by Analysts
Shares of MacroGenics, Inc. (NASDAQ:MGNX – Get Free Report) have earned an average recommendation of “Hold” from the ten analysts that are presently covering the company, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating, two have issued a buy rating and one has given a strong buy rating to […] - 2025-06-09 03:40:51
Millennium Management LLC Sells 671,179 Shares of MacroGenics, Inc. (NASDAQ:MGNX)
Millennium Management LLC reduced its stake in MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 19.0% during the fourth quarter, HoldingsChannel reports. The fund owned 2,864,721 shares of the biopharmaceutical company’s stock after selling 671,179 shares during the period. Millennium Management LLC’s holdings in MacroGenics were worth $9,310,000 as of its most recent SEC filing. Several […] - 2025-05-26 04:42:51
Dimensional Fund Advisors LP Has $2.33 Million Stock Holdings in MacroGenics, Inc. (NASDAQ:MGNX)
Dimensional Fund Advisors LP decreased its position in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 18.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 717,288 shares of the biopharmaceutical company’s stock after selling 165,372 shares during the quarter. Dimensional Fund Advisors […] - 2025-05-15 04:31:10
Price T Rowe Associates Inc. MD Lowers Stake in MacroGenics, Inc. (NASDAQ:MGNX)
Price T Rowe Associates Inc. MD decreased its stake in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 61.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 485,987 shares of the biopharmaceutical company’s stock after selling 768,249 shares during the quarter. Price T Rowe Associates Inc. MD’s holdings in MacroGenics were worth $1,581,000 […] - 2025-05-09 06:25:03
Marshall Wace LLP Raises Stock Position in MacroGenics, Inc. (NASDAQ:MGNX)
Marshall Wace LLP grew its holdings in MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 3.2% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 393,766 shares of the biopharmaceutical company’s stock after acquiring an additional 12,250 shares during the period. Marshall Wace […] - 2025-04-30 05:41:02
XTX Topco Ltd Acquires 55,564 Shares of MacroGenics, Inc. (NASDAQ:MGNX)
XTX Topco Ltd grew its holdings in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 497.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 66,742 shares of the biopharmaceutical company’s stock after acquiring an additional 55,564 shares during the […] - 2025-04-28 06:20:59
JPMorgan Chase & Co. Increases Stock Position in MacroGenics, Inc. (NASDAQ:MGNX)
JPMorgan Chase & Co. increased its holdings in shares of MacroGenics, Inc. (NASDAQ:MGNX – Free Report) by 68.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 546,807 shares of the biopharmaceutical company’s stock after buying an additional 221,905 shares during the period. JPMorgan Chase & Co.’s holdings in MacroGenics were worth $1,777,000 as […] - 2025-04-25 04:18:49
HC Wainwright Lowers MacroGenics (NASDAQ:MGNX) Price Target to $2.00
MacroGenics (NASDAQ:MGNX – Free Report) had its price objective cut by HC Wainwright from $4.00 to $2.00 in a research note released on Tuesday morning,Benzinga reports. They currently have a neutral rating on the biopharmaceutical company’s stock. Separately, StockNews.com downgraded MacroGenics from a “buy” rating to a “hold” rating in a research report on Friday, […] - 2025-03-26 04:52:44
MacroGenics, Inc. (NASDAQ:MGNX) Receives $7.63 Average PT from Analysts
MacroGenics, Inc. (NASDAQ:MGNX – Get Free Report) has been given an average recommendation of “Hold” by the eleven analysts that are covering the stock, MarketBeat Ratings reports. Eight research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has assigned a strong buy rating to the company. […] - 2025-03-26 03:53:00

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) MGNX holdings

DateNumber of MGNX Shares HeldBase Market Value of MGNX SharesLocal Market Value of MGNX SharesChange in MGNX Shares HeldChange in MGNX Base ValueCurrent Price per MGNX Share HeldPrevious Price per MGNX Share Held
2025-11-11 (Tuesday)39,640USD 60,253MGNX holding increased by 3568USD 60,2530USD 3,568 USD 1.52 USD 1.42999
2025-11-10 (Monday)39,640MGNX holding increased by 106USD 56,685MGNX holding increased by 2523USD 56,685106USD 2,523 USD 1.42999 USD 1.37001
2025-11-07 (Friday)39,534USD 54,162MGNX holding increased by 396USD 54,1620USD 396 USD 1.37001 USD 1.35999
2025-11-06 (Thursday)39,534MGNX holding increased by 106USD 53,766MGNX holding decreased by -3010USD 53,766106USD -3,010 USD 1.35999 USD 1.43999
2025-11-05 (Wednesday)39,428USD 56,776MGNX holding decreased by -395USD 56,7760USD -395 USD 1.43999 USD 1.45001
2025-11-04 (Tuesday)39,428MGNX holding increased by 107USD 57,171MGNX holding decreased by -4956USD 57,171107USD -4,956 USD 1.45001 USD 1.58
2025-11-03 (Monday)39,321USD 62,127MGNX holding decreased by -3146USD 62,1270USD -3,146 USD 1.58 USD 1.66
2025-10-31 (Friday)39,321USD 65,273MGNX holding increased by 2556USD 65,2730USD 2,556 USD 1.66 USD 1.595
2025-10-30 (Thursday)39,321MGNX holding increased by 535USD 62,717MGNX holding decreased by -2831USD 62,717535USD -2,831 USD 1.595 USD 1.68999
2025-10-29 (Wednesday)38,786MGNX holding increased by 214USD 65,548MGNX holding decreased by -5810USD 65,548214USD -5,810 USD 1.68999 USD 1.84999
2025-10-28 (Tuesday)38,572USD 71,358MGNX holding decreased by -2315USD 71,3580USD -2,315 USD 1.84999 USD 1.91001
2025-10-27 (Monday)38,572USD 73,673MGNX holding increased by 2701USD 73,6730USD 2,701 USD 1.91001 USD 1.83999
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of MGNX by Blackrock for IE00BYXG2H39

Show aggregate share trades of MGNX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY1061.4451.370 1.378USD 146 2.13
2025-11-06BUY1061.4301.355 1.363USD 144 2.14
2025-11-04BUY1071.5651.430 1.443USD 154 2.14
2025-10-30BUY5351.7001.580 1.592USD 852 2.15
2025-10-29BUY2141.6901.860 1.843USD 394 2.15
2025-10-22SELL-4281.9502.150 2.130USD -912 2.16 Profit of 14 on sale
2025-10-20BUY2141.7101.806 1.796USD 384 2.17
2025-10-17BUY5331.6501.740 1.731USD 923 2.17
2025-10-15BUY8481.6901.770 1.762USD 1,494 2.17
2025-10-03BUY7421.7801.830 1.825USD 1,354 2.18
2025-10-02BUY1061.7101.740 1.737USD 184 2.18
2025-09-30BUY2121.6801.775 1.765USD 374 2.18
2025-09-26BUY2121.7301.740 1.739USD 369 2.19
2025-09-25BUY2121.6501.690 1.686USD 357 2.19
2025-09-18BUY1061.7301.745 1.744USD 185 2.20
2025-09-17BUY3181.5301.625 1.615USD 514 2.20
2025-08-20SELL-4241.4901.505 1.503USD -637 2.22 Profit of 303 on sale
2025-07-30BUY4241.5401.604 1.598USD 677 2.24
2025-07-17SELL-2121.5401.605 1.599USD -339 2.28 Profit of 144 on sale
2025-07-11SELL-8481.6101.620 1.619USD -1,373 2.30 Profit of 577 on sale
2025-07-07BUY3181.3601.450 1.441USD 458 2.32
2025-07-02BUY5,7751.3801.407 1.404USD 8,110 2.33
2025-06-11BUY2101.7102.010 1.980USD 416 2.39
2025-06-10BUY2101.7802.170 2.131USD 448 2.39
2025-06-04SELL-1051.5001.535 1.531USD -161 2.42 Profit of 93 on sale
2025-04-23BUY1051.7101.790 1.782USD 187 2.68
2025-04-10SELL-8401.2501.290 1.286USD -1,080 2.82 Profit of 1,287 on sale
2025-04-08SELL-1051.1001.150 1.145USD -120 2.86 Profit of 180 on sale
2025-04-07SELL-1051.1001.115 1.114USD -117 2.88 Profit of 185 on sale
2025-04-04SELL-5301.0601.130 1.123USD -595 2.90 Profit of 941 on sale
2025-04-01BUY4201.2201.299 1.291USD 542 2.94
2025-03-31SELL-3181.2701.300 1.297USD -412 2.96 Profit of 528 on sale
2025-03-14SELL-1,6962.2202.270 2.265USD -3,841 3.12 Profit of 1,458 on sale
2025-03-07SELL-2122.2702.440 2.423USD -514 3.19 Profit of 162 on sale
2025-03-04SELL-1062.3202.340 2.338USD -248 3.23 Profit of 94 on sale
2025-02-25BUY2122.5402.670 2.657USD 563 3.30
2025-02-19SELL-1062.9102.950 2.946USD -312 3.33 Profit of 41 on sale
2025-02-13BUY3182.4602.485 2.482USD 789 3.39
2025-02-12BUY1062.4002.430 2.427USD 257 3.41
2025-02-11BUY4242.4002.530 2.517USD 1,067 3.43
2024-12-30SELL-5303.2303.265 3.262USD -1,729 3.63 Profit of 195 on sale
2024-11-18SELL-1,5903.5103.710 3.690USD -5,867 3.82 Profit of 210 on sale
2024-11-08SELL-1064.3504.540 4.521USD -479 3.76 Loss of -80 on sale
2024-10-21SELL-1063.8603.995 3.981USD -422 0.00 Loss of -422 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of MGNX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1971,330100274,18026.0%
2025-09-1884,2390488,18817.3%
2025-09-17149,842930446,61133.6%
2025-09-16169,0016,800507,01533.3%
2025-09-15159,8820363,37144.0%
2025-09-1275,2650230,70432.6%
2025-09-11106,7710522,20820.4%
2025-09-1028,8190206,20614.0%
2025-09-0929,3937,727326,9269.0%
2025-09-08268,20832,949949,26728.3%
2025-09-05172,21901,685,91010.2%
2025-09-0496,6540399,17424.2%
2025-09-03175,738951691,71125.4%
2025-09-02227,0300773,23129.4%
2025-08-2997,1160380,03725.6%
2025-08-2846,8700211,23822.2%
2025-08-2757,2730211,85027.0%
2025-08-26158,6290848,26418.7%
2025-08-2599,701390539,97818.5%
2025-08-22180,0752,352918,32819.6%
2025-08-2111,335083,83513.5%
2025-08-2029,0090141,99520.4%
2025-08-1940,2080203,52019.8%
2025-08-1836,624300248,32814.7%
2025-08-1560,1250223,83326.9%
2025-08-1484,8990295,67228.7%
2025-08-1363,1540262,58124.1%
2025-08-1226,5720251,31110.6%
2025-08-1172,3560230,42531.4%
2025-08-0838,2780106,72535.9%
2025-08-0734,93186104,45433.4%
2025-08-0650,6690137,79836.8%
2025-08-0563,9210234,80427.2%
2025-08-0428,53088122,82623.2%
2025-08-0170,4940337,93420.9%
2025-07-3160,6350285,99021.2%
2025-07-30173,1400774,86022.3%
2025-07-2930,8570180,81817.1%
2025-07-2845,5842,356229,50519.9%
2025-07-25118,02694292,41740.4%
2025-07-24105,7810463,60722.8%
2025-07-23225,28926,172915,44424.6%
2025-07-2285,0630263,79432.2%
2025-07-2120,9230158,13113.2%
2025-07-1843,834200169,69625.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.